PROTEIN A RESIN MARKET ANALYSIS

Protein A Resin Market, By Product (Natural Protein A and Recombinant Protein A), By Matrix Type (Agarose-based, Glass or Silica Based, and Organic Polymer Based), By Application (Immunoprecipitation and Antibody Purification), By End User (Biopharmaceutical Companies, Clinical Research Laboratories, and Academic Institutes), By Geography (North America, Latin America, Europe, Asia Pacific, Middle East & Africa)

Published In : Jun 2024
Code : CMI231
Pages :163
Formats :
Excel and PDF
Industry : Pharmaceutical

Market Concentration and Competitive Landscape

Protein A Resin Market Concentration By Players

Close-monitor your Competitor's Move, Request sample copy

Growth of Biosimilars Industry

The commercialization of many blockbusters biologic drugs is expected to lose patent protection in the upcoming years, opening vast opportunities for biosimilar products. Several pharmaceutical vendors are entering the biosimilars space and are engaged in the development of low-cost versions of popular biologics like monoclonal antibodies, hormones, cytokines, and clotting factors. Since protein A resin demonstrates high affinity and specificity for immunoglobulin G (IgG) molecules, it serves as an imperative technology in the downstream purification step of biosimilar manufacturing processes. The increasing biosimilars approvals and expanding global biosimilars market size will propel the demand for protein A resins from biosimilar companies. Many leading players are also focusing on enhancing protein A resin capabilities to fast-track the production of biosimilars. This is anticipated to substantially augment the growth of the protein A resin market in the foreseeable future.

Key Players Insights